Bausch Health Companies Inc. Common Stock (BHC)
R&D to Revenue
6.07%
Quarterly · Period ending:
BHC R&D to Revenue
Latest reported6.07%period ending
Latest reported6.07%period ending
BHC Quarterly R&D/Revenue (0.00% → 6.07%)
Latest values, visible window
High-resolution chart · PNG
BHC r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 10.4214% | |
| 9.5675% | |
| 3.7446% | |
| 25.6086% | |
| 23.0667% | |
| 25.1088% | |
| 20.4511% | |
| 17.2564% | |
| 17.9558% | |
| 19.2092% | |
| 14.4414% | |
| 13.7931% | |
| 16.2055% | |
| 18.2648% | |
| 0% | |
| 23.1132% | |
| 12.4324% | |
| 18.9024% | |
| 11.5108% | |
| 10.1124% | |
| 10.929% | |
| 12.3348% | |
| 0% | |
| 0% | |
| 0% | |
| 10.9091% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |